← FDA DRUG APPROVALS

FDA ANDA · ANDA070333

METHYLDOPA

Sponsor: PARKE DAVIS

APPLICATION
ANDA070333
TYPE
ANDA
ORIGINAL APPROVAL
1986-04-15
LATEST ACTION
1991-07-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

METHYLDOPADiscontinued
METHYLDOPA 500MG · TABLET · ORAL

Approval history

1991-07-23Labeling · Supplement 9AP
1989-11-14Labeling · Supplement 2AP
1989-11-03Labeling · Supplement 6AP
1989-11-03Labeling · Supplement 4AP
1986-04-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →